Table 1.
Vaccine dose (μg) | + Electroporation |
− Electroporation |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Vaccinated birds at 56 dpvb,c |
Seroconversion during course of expt |
Vaccinated birds at day 56 dpv |
Seroconversion during the course of expt |
|||||||||
Total no. | GMT | Range of endpoint titer | No. of seropositive birds/total no. of immunized | Earliest detection (avg dpv) | Antibody persistence (avg no. of days)d | Total no. | GMT | Range of endpoint titer | No. of seropositive birds/total no. of immunized | Earliest detection (avg dpv) | Antibody persistence (avg no. of days) | |
0 | 5 | 1 | 1 | 0/5 | Not detectede | 0 | 10 | 1 | 1 | 0/10 | Not detectede | 0 |
10 | 13 | 9.2 | 1–128 | 7/13 | 36.4 | 13.4 | 13 | 1 | 1 | 2/13 | 32.5 | 1 |
100 | 12 | 48.5 | 1–128 | 11/12 | 29.1 | 27.9 | 12 | 1 | 1–8 | 1/12 | 56 | 1 |
250 | 5 | 42.2 | 16–128 | 5/5 | 20.2 | 23.4 | 5 | 1 | 1–8 | 1/5 | 44 | 1 |
HI, hemagglutination inhibition.
dpv, days postvaccination; GMT, geometric mean titer.
Samples testing negative by the HI test were ascribed a titer of 1 for the purpose of calculating the GMT. An HI titer of ≥4 (i.e., 1:4) was considered positive. Endpoint dilution values were converted to log2, and the GMT was determined and expressed as the endpoint mean titer after a reconversion.
The study design allowed only for measuring antibody persistence to a maximum of 43 days before termination of the experiment.
Not detected indicates that none of the chickens tested positive at any of the sampling times.